Observational studyJapanese journal of clinical oncology2025

Clinical outcomes of patients with EGFR-mutated NSCLC developing interstitial lung disease during first-line osimertinib therapy: a sub-analysis of the Reiwa study.

Takayuki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.